Developing a Claim-based Version of the ACE-27 Comorbidity Index
A Comparison With Medical Record Review
Datos Bibliográficos
| ID | 9105020 |
|---|---|
| Autores | Steven T Fleming (University of Kentucky), Susan A Sabatino, Gretchen Kimmick (0000-0001-7096-9624, Duke University), Rosemary D Cress (University of California, Davis), Rosemary Cress, Xiao-Cheng Wu, Xiao‐Cheng Wu (0000-0003-3663-5027, Louisiana State University Health Sciences Center New Orleans), Amy Trentham-Dietz, Amy Trentham‐Dietz (0000-0002-5971-4660, University of Wisconsin–Madison), Bin Huang (0000-0001-9724-675X, University of Kentucky), Wenke Hwang (0000-0002-8116-807X), Jonathan Liff (Emory University) |
| Año | 2011 |
| Volumen | 49 |
| Número | 8 |
| Páginas | 752-760 |
| Fecha de publicación | 2011-08-01 |
| Peer Reviewed | Sí |
| Open Access | No |
| Tipo | ARTICLE |
| Revista | Medical Care (JOURNAL) |
| Identificadores de la revista | ISSN: 0025-7079 • E-ISSN: 1537-1948 |
| Editorial | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/mlr.0b013e318215d7dd |
| PMID | 21490514 |
| OpenAlex | W2037682409 |
| Idioma | EN |
| Citas recibidas | 6 |
| Referencias citadas | 32 |
OBJECTIVES: The adult comorbidity evaluation (ACE-27) is a medical record-based comorbidity index that predicts survival among various types of cancer patients. The purpose of this study was to compare the medical record-based ACE-27 instrument to a newly developed administrative claim-based ACE-27 measure. STUDY DESIGN AND SETTING: Cross-sectional study of 4,300 breast and prostate cancer patients from the Centers for Disease Control and Prevention Patterns of Care Study. RESULTS: Comorbidities with the highest concordance were diabetes (sensitivity=84.6%, κ=0.58 for breast cancer patients; sensitivity=0.764, κ=0.54 for prostate cancer patients), and hypertension (sensitivity=78.5%, κ=0.32 for breast cancer patients; sensitivity=69.6%, κ=0.28 for prostate cancer patients). Diseases with fair or moderate agreement in one or both cancer sites include congestive heart failure, arrhythmia, hypertension, respiratory diseases, hepatic disease, renal disease, dementia, and neuromuscular disease. For overall indices, agreement was fair but with high sensitivities in the collapsed indices, and the highest sensitivities in the lowest level of decompensation. CONCLUSIONS: The ACE-27 comorbidity score derived from administrative claims data provides a tool to examine the relationship between comorbidity, cancer diagnosis, and outcomes in future epidemiologic research, particularly when medical record review is logistically impossible. The classification of most comorbidities into 2 or 3 levels of severity within a claim-based measure is a major development. Future research should be directed toward refining the measure with a longer review period or different paradigms for diagnosis identification, and testing the predictive ability of the measure in terms of survival, complications, or other outcomes of care
Breast cancer · Cancer · Cancer registry · Comorbidity · Concordance · Diabetes mellitus · Disease · Intensive care medicine · Physical therapy · Prostate cancer · Cancer survivorship and care · Chronic Disease Management Strategies · Frailty in Older Adults · Internal Medicine · Medicine
Examination of individual and multiple comorbid conditions and health-related quality of life in older cancer survivors
Receipt of Regular Primary Care and Early Cancer Detection in Appalachia
Disparities in Colorectal Cancer Treatment Delay Within Appalachia—The Role of For‐Profit Hospitals
Patterns of Care for Metastatic Colorectal Cancer in Appalachia, and the Clinical, Sociodemographic, and Service Provider Determinants
Clinical, Sociodemographic, and Service Provider Determinants of Guideline Concordant Colorectal Cancer Care for Appalachian Residents
The Relative Ability of Comorbidity Ascertainment Methodologies to Predict In-Hospital Mortality Among Hospitalized Community-acquired Pneumonia Patients
Development of a comorbidity index using physician claims data
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
How to measure comorbiditya critical review of available methods
A new method of classifying prognostic comorbidity in longitudinal studies
Underutilization of Mammography in Older Breast Cancer Survivors
Data Sources for Measuring Comorbidity
Comorbidity as a Predictor of Stage of Illness for Patients With Breast Cancer
Comorbidity Measures for Use with Administrative Data
Comorbidity Indices to Predict Mortality From Medicare Data
A Comprehensive Prognostic Index to Predict Survival Based on Multiple Comorbidities
| Obras citantes distintas | 6 |
|---|---|
| Citas por año | 0,5 |
| Intervalo de citas | 2014 - 2021 (8) |
| Velocidad de citación | historical |
| Altamente citado | No |
| Tipos de cita | Neutras: 6 |